Three items today: one market, one policy, one deals watch. No new Australian GP transaction. The clearest signal is at the other end of the market: Kalbarri's only GP clinic has closed, a marker of where sellable independent stock is disappearing. And the ATO has still not issued the valuation guidance every practice owner needs before the 1 July 2027 CGT reset.
Kalbarri Doctors Surgery, the town's only general practice, closed on 26 June 2026. Christopher Hamilton, director of operator Medibloom Group, said every option to keep it open had been exhausted and the clinic was no longer financially viable after moving to a fully bulk-billed model. The RACGP put the arithmetic plainly: Medicare indexation of 2.6% against CPI of 4.2% over the past year, and 'goodwill is not a funding model'. The College framed it as a funding problem across general practice, not a Kalbarri problem.
For buy-side logic this is the floor of the market. A sole regional practice that cannot be made viable under bulk billing does not become an acquisition target, it closes. That reinforces two threads this brief tracks: the thinning of the regional independent segment as sellable stock, and the concentration of corporate and insurer interest in metro and large-suburban multi-doctor clinics where those buyers actually operate. Where a viable sale is not achievable, closure is the exit.
The enacted CGT reform deems assets held by resident individuals and trusts on 30 June 2027 to be sold immediately before 1 July 2027 and reacquired at market value. From that point the 50% discount is replaced by cost base indexation, and a 30% minimum tax applies to gains arising after 1 July 2027. The reset value sets the new cost base. The ATO has not yet released guidance on acceptable valuation methodologies for that reset, and advisers at Andersen and PwC flag it as urgently needed.
For practice owners this is the operative gap. An owner holding goodwill and rooms needs a defensible market value at 30 June 2027 to fix the new cost base, and without ATO valuation guidance firm pre-July-2027 planning cannot be finalised. For buyers the effect is indirect: valuation uncertainty at the reset may shape how vendors price and structure ahead of the change.
This is general information, not tax or legal advice. Practice-level and timing questions belong with your own advisers.
Bupa-Partnered Health (announced 18 June, 68 primary care and three urgent care clinics) is still not listed on the ACCC acquisitions register and remains subject to ACCC and FIRB clearance. If completed, Bupa reaches about 100 clinics, fifth on the operator ladder. AvidSys / Avid Health-Spectrum Health (WA, about 38 owned practices) completion is still unconfirmed. Medibank / Amplar sits at about 168 to 170 clinics, including the completed A$159m Better Medical acquisition. No new listed-operator results: Sonic's full-year FY2025-26 result is expected around August, with EBITDA guidance of A$1.87 to 1.95bn at constant currency.
Own a practice and thinking about your exit, this year or in three? Write to kate.marie@mediusglobal.com.au, in confidence.
Buying, lending or researching? The full operator dataset behind the Zoo is licensed: get the full data.